Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

John H. Krege,Paul Rizzoli,Emily Liffick,Erin G. Doty,Sherie A. Dowsett,Jianing Wang,Andrew S. Buchanan

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

2019

John H. Krege
Paul Rizzoli
Emily Liffick
Erin G. Doty
Sherie A. Dowsett
Jianing Wang
Andrew S. Buchanan

BackgroundWe assessed the safety profile of lasmiditan, a selective 5-HT1F receptor agonist without vasoconstrictive activity being developed as an acute therapy for migraine.MethodsSAMURAI and SPA...

Keywords:

Anesthesia
Lasmiditan
Physical therapy
Migraine
Spartan
Medicine
safety profile
Agonist

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations